Noemi Sigalove

Noemi Sigalove, MD

Breast Surgery
Languages: English
HonorHealth Medical Staff Member

Insurance accepted

Please select a health insurance provider to view HonorHealth accepted plans.

Insurance Plans

  • AHCCCS Complete Care.
  • AHCCCS CRS
  • Dual-SNP
  • 3 Tier Plans
  • Banner Employees - Tier 2
  • HMO
  • PPO
  • EPO
  • Ameriben
  • POS
  • Indemnity
  • CHS
  • Alliance Network
  • FEP (Standard, Basic and Blue Focus),
  • Workers' Comp
  • EverydayHealth PPO,
  • BluePathway Plan 2 - Medicare Advantage
  • BluePathway Plan 3 - - Medicare Advantage
  • BlueJourney PPO - Medicare Advantage
  • Classic/Plus - Medicare Advantage
  • Medisun - Medicare Advantage
  • All
  • HMO
  • PPO
  • PPO Plus
  • POS
  • EPO
  • LocalPlus
  • Open Access Plan (OAP)
  • CignaChoice Fund Access Plus
  • Open Access Plus
  • PPO
  • RAN
  • PPO

HonorHealth accepts most health insurance plans at its hospitals and physician offices. However, you need to contact your health insurance company to verify your coverage for individual physicians/providers and their physicians before you seek services.

Specialties

  • Breast Surgery

Credentials

  • Residency

    Rush University Medical Center
  • Education

    Rush Medical College of Rush University Medical Center
  • Board Certifications

    American Board of Surgery - Surgery

About

HonorHealth Cancer Care gives you access to an elite team of experts across the Valley. The physicians we collaborate with are nationally and internationally recognized.

Dr. Sigalove is board-certified by the American Board of Surgery, and has written textbook chapters and medical journal articles on the topics of breast health and mastectomy technique. Partnering with her husband, a reconstructive surgeon, Dr. Sigalove has helped advance novel surgical techniques that minimize pain, maximize recovery and enhance the appearance of the reconstructed breast. She focuses on care with compassion and emphasizes a team approach to fighting cancer. She strives to achieve the most optimal cancer treatment with the least amount of disfigurement to the breast.